Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor who are in complete radiological remission: A prospective multicenter phase II study.

被引：0
作者：
Hompland, Ivar
Boye, Kjetil
Papakonstantinou, Andri
Rosok, Bard
Joensuu, Heikki
Bruland, Oyvind
机构：
[1] Oslo Univ Hosp, Oslo, Norway
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Oncoinvent AS, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11535
引用
收藏
页数：1
相关论文
共 50 条
[21]   Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial [J].
Mahon, Francois-Xavier ;
Rea, Delphine ;
Guilhot, Joelle ;
Guilhot, Francois ;
Huguet, Francoise ;
Nicolini, Franck ;
Legros, Laurence ;
Charbonnier, Aude ;
Guerci, Agnes ;
Varet, Bruno ;
Etienne, Gabriel ;
Reiffers, Josy ;
Rousselot, Philippe .
LANCET ONCOLOGY, 2010, 11 (11) :1029-1035
[22]   Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor [J].
Chi, Ping ;
Li-Xuan Qin ;
Nguyen, Bastien ;
Kelly, Ciara M. ;
D'Angelo, Sandra P. ;
Dickson, Mark A. ;
Gounder, Mrinal M. ;
Keohan, Mary L. ;
Movva, Sujana ;
Nacev, Benjamin A. ;
Rosenbaum, Evan ;
Thornton, Katherine A. ;
Crago, Aimee M. ;
Yoon, Sam ;
Ulaner, Gary ;
Yeh, Randy ;
Martindale, Moriah ;
Phelan, Haley T. ;
Biniakewitz, Matthew D. ;
Warda, Sarah ;
Lee, Cindy J. ;
Berger, Michael F. ;
Schultz, Nikolaus D. ;
Singer, Samuel ;
Hwang, Sinchun ;
Chen, Yu ;
Antonescu, Cristina R. ;
Tap, William D. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (09) :997-+
[23]   Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study [J].
Naito, Yoichi ;
Doi, Toshihiko ;
Takahashi, Tsuyoshi ;
Kudo, Toshihiro ;
Boku, Narikazu ;
Honma, Yoshitaka ;
Komatsu, Yoshito ;
Nakatsumi, Hiroshi ;
Matsumoto, Koji ;
Onoe, Takuma ;
Oki, Eiji ;
Tsuda, Yasuo ;
Nakamoto, Masako ;
Fukutani, Miki ;
Nomura, Shogo ;
Sato, Akihiro ;
Nishida, Toshirou .
ANNALS OF ONCOLOGY, 2019, 30 :88-88
[24]   Phase II trial of nintedanib in patients with recurrent or metastatic salivary gland cancer: A multicenter phase II study. [J].
Kim, Youjin ;
Lee, Su Jin ;
Park, Keunchil ;
Lee, Se-hoon ;
Sun, Jong Mu ;
Keam, Bhumsuk ;
An, Ho Jung ;
Cho, Jae Yong ;
Kim, Jin-Soo ;
Lee, Ha-young ;
Kim, HyeRyun ;
Lee, Kyoung Eun ;
Choi, Moon Young ;
Lee, Ki Hyeong ;
Ahn, Myung-Ju .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[25]   A phase Ib/II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST) [J].
Chi, Ping ;
Qin, Li-Xuan ;
D'Angelo, Sandra P. ;
Dickson, Mark Andrew ;
Gounder, Mrinal M. ;
Keohan, Mary Louise ;
Shoushtari, Alexander Noor ;
Condy, Mercedes M. ;
Konen, Theresa ;
Fruauff, Alana ;
DeMatteo, Ronald P. ;
Singer, Samuel ;
Hwang, Sinchun ;
Antonescu, Cristina R. ;
Tap, William D. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[26]   Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate [J].
Kuniaki Shirao ;
Toshirou Nishida ;
Toshihiko Doi ;
Yoshito Komatsu ;
Kei Muro ;
Yinhua Li ;
Eiji Ueda ;
Atsushi Ohtsu .
Investigational New Drugs, 2010, 28 :866-875
[27]   A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST). [J].
Chi, Ping ;
Qin, Li-Xuan ;
Kelly, Ciara Marie ;
D'Angelo, Sandra P. ;
Dickson, Mark Andrew ;
Gounder, Mrinal M. ;
Keohan, Mary Louise ;
Movva, Sujana ;
Nacev, Benjamin ;
Crago, Aimee Marie ;
Yoon, Sam S. ;
Ulaner, Gary A. ;
Martindale, Moriah ;
Condy, Mercedes M. ;
Biniakewitz, Haley Phelan Matthew ;
Singer, Samuel ;
Hwang, Sinchun ;
Antonescu, Cristina R. ;
Tap, William D. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[28]   Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate [J].
Shirao, Kuniaki ;
Nishida, Toshirou ;
Doi, Toshihiko ;
Komatsu, Yoshito ;
Muro, Kei ;
Li, Yinhua ;
Ueda, Eiji ;
Ohtsu, Atsushi .
INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) :866-875
[29]   Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group [J].
Park, S. H. ;
Ryu, M. H. ;
Ryoo, B. Y. ;
Im, S. A. ;
Kwon, H. C. ;
Lee, S. S. ;
Park, S. R. ;
Kang, B. Y. ;
Kang, Y. K. .
INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) :2377-2383
[30]   Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group [J].
S. H. Park ;
M. H. Ryu ;
B. Y. Ryoo ;
S. A. Im ;
H. C. Kwon ;
S. S. Lee ;
S. R. Park ;
B. Y. Kang ;
Y. K. Kang .
Investigational New Drugs, 2012, 30 :2377-2383
12345